Immune modulatory nanoparticle therapeutics for intracerebral glioma

Abstract

For the first time, we show that nanoparticles can direct a therapeutic response by targeting intracellular immune pathways. Although shown in the context of gliomas, this therapeutic approach would be applicable to other malignancies.